Live
Endpoints NewsLilly to acquire three vaccine biotechs for up to $3.8BEndpoints NewsAstellas’ five-year plan includes chasing record sales and cost cutsBioPharma DiveSR One’s Simeon George on how China is rewriting biotech’s venture playbookEndpoints NewsLilly reports new data on PCSK9 base editing gene therapy from Verve buyoutEndpoints NewsAdtech company Swoop buys pharmacy startup NimbleRxBioPharma DiveMeasuring what matters: New priorities in COA selectionBioPharma DiveProcess intensification: Separating fact from fictioneLifeCognitive simplicity drives collective route improvements in homing pigeonseLifeInhibitory columnar feedback neurons are involved in motion processing in <i>Drosophila</i>eLifeHyperactivated glycolysis drives spatially patterned Kupffer cell depletion in MASLDeLifeMulti-talker speech comprehension at different temporal scales in listeners with normal and impaired hearingNovo NordiskOral Wegovy And Cancer Signals Reframe Novo Nordisk GLP 1 Opportunity - simplywall.st
BioPharma Dive Apr 9, 2026

Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk

Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk

Original
Body unavailable. Use the original source.